Metrics as of 10/15/2026, 08:33 AM (Berlin time), refresh in progress.
SKAN Group Stock
SKAN Group AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- Switzerland
- CEO
- Jonas Greutert
- Employees
- 1,694
- Market cap
- CHF1.6 B
- IPO
- 28/12/2021
- Web
- skan.com/de
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors. The company offers advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. Headquartered in Allschwil, Switzerland, the company was founded in 1968…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
SKAN Group stock: price history
1D
-0.3%
1W
+3.3%
1M
+15.9%
6M
+47.9%
YTD
+38.3%
1Y
+37.7%
2Y
-5.2%
5Y
–
10Y
–
Next earnings date
Next earnings date
23/03/2027 (in 157 days)
Volatility around earnings
~25% stronger price swings than usual
SKAN Group stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
SKAN Group AG is a global leader in high-tech solutions for the pharma and chemical sectors. The company offers advanced isolators, cleanroom technologies and decontamination processes. Operations are divided into two business segments: Equipment and Solutions (E&S), which supplies complex systems such as automated equipment and aseptic filling solutions, and Services and Consumables (S&C), which encompasses lifetime support, consumables and digital solutions. Through this model, SKAN combines the sale of technical hardware with recurring revenues from service offerings and specialized consumables for pharmaceutical manufacturing.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Weak
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about SKAN Group
SKAN Group stock metrics
P/E
54.89
P/B
14.44
EV/EBITDA
28.84
RETURN ON EQUITY
4.2%
NET MARGIN
2.9%
DEBT/EQUITY
1.15
DIVIDEND YIELD
0.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
56.5%
FLOAT SHARES
12,699,150
AVG. DAILY VOLUME (30D)
45,524
Dividends
Comparable stocks
Frequently asked questions about SKAN Group stock
What does SKAN Group do?
SKAN Group AG is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in Switzerland.
The CEO is Jonas Greutert, the company employs around 1,694 people.
The IPO was on 28/12/2021; the stock trades on SIX under the ticker SKAN.SW.
When does SKAN Group report next?
The next earnings date is 23/03/2027.
Around past earnings, price swings were roughly 25% stronger than usual.
Does SKAN Group pay a dividend?
Yes. The last dividend was CHF 0.22 per share, ex-date 11/05/2026, paid on 13/05/2026.
The dividend yield is 0.3% (as of 30/06/2026).
Which stocks are comparable to SKAN Group?
Comparable stocks include Tecan Group, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Sartorius, Solventum and Baxter International.
How can I get SKAN Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess SKAN Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.